Prevention of Ulcerative Colitis by Autologous Metabolite Transfer from Colitogenic Microbiota Treated with Lipid Nanoparticles Encapsulating an Anti-Inflammatory Drug Candidate

Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation

(2021) Carlo Romano Settanni et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Fecal Microbiota Transplantation

(2021) Sanchit Gupta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Orally Administered Natural Lipid Nanoparticle-Loaded 6-Shogaol Shapes the Anti-Inflammatory Microbiota and Metabolome

(2021) Chunhua Yang et al.   Pharmaceutics

Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway

(2020) Ji Hyun Choi et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Delivery routes for faecal microbiota transplants: Available, anticipated and aspired

(2020) Monica Gulati et al.   PHARMACOLOGICAL RESEARCH

Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis

(2020) Chunhua Yang et al.   JOURNAL OF CONTROLLED RELEASE

Oral Gavage of Ginger Nanoparticle-derived Lipid Vectors Loaded with Dmt1 siRNA Mitigates Iron Loading in Murine Hereditary Hemochromatosis

(2019) Xiaoyu Wang et al.   MOLECULAR THERAPY

Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems

(2019) Constantin Mircioiu et al.   Pharmaceutics

Intestinal microbiome as a novel therapeutic target for local and systemic inflammation

(2019) Kazuhiko Uchiyama et al.   PHARMACOLOGY & THERAPEUTICS

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome

(2019) Israr Khan et al.   Pathogens

Improved succinate production from galactose‐rich feedstocks by engineered Escherichia coli under anaerobic conditions

(2019) Fayin Zhu et al.   BIOTECHNOLOGY AND BIOENGINEERING

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2019) Sudabeh Alatab et al.   Lancet Gastroenterology & Hepatology

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease

(2018) Allison Agus et al.   Cell Host & Microbe

Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines

(2018) Chunhua Yang et al.   Journal of Materials Chemistry B

Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota

(2018) Yun Teng et al.   Cell Host & Microbe

Gut microbiota functions: metabolism of nutrients and other food components

(2017) Ian Rowland et al.   EUROPEAN JOURNAL OF NUTRITION

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans

(2017) Emilie Viennois et al.   Scientific Reports

Probiotic Lactobacillus Strains Stimulate the Inflammatory Response and Activate Human Macrophages

(2017) L. M. Rocha-Ramírez et al.   Journal of Immunology Research

Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer

(2016) Mingzhen Zhang et al.   BIOMATERIALS

In vitro release kinetics model fitting of liposomes: An insight

(2016) Ankit Jain et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health

(2016) Pamela Vernocchi et al.   Frontiers in Microbiology

The gut microbiota and host health: a new clinical frontier

(2015) Julian R Marchesi et al.   GUT

A Multihit Model

(2015) Lydia M. Keubler et al.   INFLAMMATORY BOWEL DISEASES

Fecal Microbiota Transplant: Benefits and Risks

(2015) A. A. Weil et al.   Open Forum Infectious Diseases

The gut microbiota, bacterial metabolites and colorectal cancer

(2014) Petra Louis et al.   NATURE REVIEWS MICROBIOLOGY

Metabolites of Ginger Component [6]-Shogaol Remain Bioactive in Cancer Cells and Have Low Toxicity in Normal Cells: Chemical Synthesis and Biological Evaluation

(2013) Yingdong Zhu et al.   PLoS One

Host-Gut Microbiota Metabolic Interactions

(2012) J. K. Nicholson et al.   SCIENCE

Inflamed gut mucosa: downstream of interleukin-10

(2011) Gregor Paul et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Differential Selectivity of the Escherichia coli Cell Membrane Shifts the Equilibrium for the Enzyme-Catalyzed Isomerization of Galactose to Tagatose

(2008) J.-H. Kim et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY